Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Deals
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Deals
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Deals
BioSpace Movers & Shakers, Oct. 30
Deals
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Deals
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Deals
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Commercial
Deals
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Deals
Deals
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
Biospace News
-
November 10, 2020
Deals
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Biospace News
-
November 5, 2020
Deals
FTC nod clears way for merger between Pfizer’s Upjohn unit, Mylan...
Firstwordpharma News
-
October 31, 2020
0
Deals
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases – FirstWord...
Firstwordpharma News
-
October 31, 2020
0
Deals
X-37, LLC Appoints David Gluckman, M.D., to Board of Directors
Biospace News
-
October 30, 2020
0
Deals
Antibe Therapeutics Receives Conditional Approval to Graduate to the Toronto Stock...
Biospace News
-
October 30, 2020
0
Deals
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November...
Biospace News
-
October 30, 2020
0
1
2
3
...
249
Page 1 of 249
- Advertisement -
LATEST NEWS
Novartis drops Aduro’s STING agonist ADU-S100 from portfolio
Firstwordpharma News
-
December 18, 2019
0
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections – FirstWord Pharma
March 24, 2020
Sun Pharmaceutical Industries, Inc. Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the U.S. For Potential COVID-19 Treatment – FirstWord Pharma
March 29, 2020
MUST READ
Eisai’s Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer...
Biospace News
-
July 17, 2019
0
Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing Phase 2B Study...
Firstwordpharma News
-
October 29, 2019
0
Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System – FirstWord Pharma
Firstwordpharma News
-
March 29, 2020
0
Load more
